Mode
Text Size
Log in / Sign up
N/A N=120

Predicting Success With Hearing Aids

Hearing Loss · Presbycusis

Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcome: Primary: Words-in-noise Test — 12.6 dB S/N

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
Oct 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Words-in-noise Test
12.6
SECONDARY
Acceptable Noise Level Test
13.5
SECONDARY
International Outcomes Inventory for Hearing Aids (IOI-HA)
28.9
SECONDARY
Measure of Audiologic Rehabilitation Self-Efficacy for Hearing Aids (MARS-HA)
84.7
SECONDARY
Satisfaction With Amplification in Daily Life (SADL)
5.4
SECONDARY
Speech Spatial and Qualities of Hearing Scale (SSQ)
7.2

Summary

The primary complaint of individuals with hearing loss is difficulty understanding speech in the presence of background noise. Although hearing aids help individuals understand speech in background noise better, there is a high rate of hearing aid rejection in part due to continued difficulty understanding speech in complex listening situations. The results of this study may demonstrate that speech-in-noise test results can be a predictor of hearing aid success. The results of this study also may lead to further studies that can evaluate interventions to improve hearing aid success for individuals who are identified as unsuccessful hearing aid users.

Eligibility Criteria

Inclusion Criteria

  • adult onset of hearing loss,
  • symmetrical, sensorineural hearing loss,
  • no more than 60 dB HL hearing loss measured via an average of air conduction thresholds at .5, 1, and 2 kHz in each ear, and
  • use of binaural hearing aids of the same make and model for each ear
  • at least 3 months of hearing aid use.

Exclusion Criteria

  • enrollment in group audiologic rehabilitation classes,
  • currently using an FM system,
  • inability to read and write American English, and
  • signs of middle ear or retrocochlear pathology.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00371449). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search